Wie können die Ergebnisse software-unterstützter Tumorbeurteilung gewinnbringend in die Routine-Kommunikation mit den klinischen Zuweisern und Patienten einfließen? Herr Prof. Dr. Daniel Boll, Stv.…
GoTo
"It's a paradigm shift." This is how Prof. Ulf Teichgräber, Director of the Institute of Diagnostic and Interventional Radiology at the University Hospital Jena, describes the improvement in…
GoTo
Medical imaging contributes key diagnostic information to the evidence-based therapeutic decision process. The transformation of radiological images into a digital stream of quantitative diagnostic…
GoTo
Integrated diagnostics at LMU University Hospital Munich as the basis for personalized therapy management Heidelberg, GER – The long-standing cooperation between Mint Medical GmbH, developer of…
GoTo
Dr. Laura Oleaga from Hospital Clinìc de Barcelona explains how she and her team have benefitted from implementing mint Lesion™ in the face of an increasing volume of clinical trials. She highlights…
GoTo
“mint Analytics expands your means of structured response assessment in mint Lesion™ by instantaneous visualization of the collected data, as a whole or per individual trial,” states PD Dr. Wolfgang…
GoTo
Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials and how a software solution for tumor assessment…
GoTo
Researchers at the University Hospital Jena analyzed the response rate and safety of superselective drug-eluting beads transarterial chemoembolization (DEB-TACE) using doxorubicin-loaded 40-μm sized…
GoTo
An exploratory study [1] conducted by researchers at University Hospital Tuebingen investigated whether CT texture analysis parameters correlate with semiquantitative 18F-FDG PET parameters and…
GoTo
We talked to PD Dr. Wolfgang G. Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig Maximilians University Hospital Munich, about his experience with mint Analytics,…
GoTo